Picture of YARROW BIOSCIENCE logo

YARW — YARROW BIOSCIENCE News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapHigh Flyer

Brief: VYNE Therapeutics Q1 Net Income USD -6.249 Million

May 09 (Reuters) - VYNE Therapeutics Q1 revenue USD 98 thousand.
* Q1 EPS from cont ops USD -0.15
* Q1 basic EPS USD -0.15

Recent news on YARROW BIOSCIENCE

See all news